|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Feb 07, 2022 |
Title |
786O_1%_serum_sh2_2 |
Sample type |
SRA |
|
|
Source name |
786O_1%_serum_sh2_2
|
Organism |
Homo sapiens |
Characteristics |
treatment: 1% FBS transfection: PBRM1 shRNA #2
|
Treatment protocol |
RPMI 10% or 1% FBS
|
Extracted molecule |
total RNA |
Extraction protocol |
Poly A Illumina TruSeq V2
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina NextSeq 500 |
|
|
Description |
786O cells with PBRM1 shRNA #2 grown in RPMI with 1% RPMI
|
Data processing |
cutadapt Salmon Deseq2 Genome_build: hg38 Supplementary_files_format_and_content: Deseq2 output, normalized gene expression in TPM
|
|
|
Submission date |
Feb 04, 2022 |
Last update date |
Mar 08, 2022 |
Contact name |
David Aaron Schoenfeld |
E-mail(s) |
david.schoenfeld@yale.edu
|
Organization name |
Yale-New Haven Hospital
|
Department |
Internal Medicine
|
Street address |
20 York Street
|
City |
New Haven |
State/province |
CT |
ZIP/Postal code |
06510 |
Country |
USA |
|
|
Platform ID |
GPL18573 |
Series (2) |
GSE102807 |
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 |
GSE196129 |
The effects of PBRM1 loss on the ccRCC transcriptome |
|
Relations |
BioSample |
SAMN25651569 |
SRA |
SRX14043267 |
Supplementary file |
Size |
Download |
File type/resource |
GSM5860595_786O_94_1__2_quant.sf.gz |
2.4 Mb |
(ftp)(http) |
SF |
SRA Run Selector |
Raw data are available in SRA |
Processed data provided as supplementary file |
|
|
|
|
|